Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exagen Inc. - Common Stock (NQ:XGN)

6.770 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.770
Bid (Size) 6.400 (10)
Ask (Size) 7.270 (1)
Prev. Close 6.770
Today's Range 6.770 - 6.770
52wk Range 1.710 - 7.950
Shares Outstanding 16,126,784
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
From Exagen Inc.
Via GlobeNewswire

Performance

YTD
+119.1%
+119.1%
1 Month
-0.6%
-0.6%
3 Month
+59.3%
+59.3%
6 Month
+34.3%
+34.3%
1 Year
+258.2%
+258.2%

More News

Read More
Top movers in Thursday's pre-market session
Via Chartmill
Earnings Scheduled For May 5, 2025
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Exagen Inc. Prices Public Offering of Common Stock
From Exagen Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Exagen Inc. Announces Proposed Public Offering of Common Stock
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights
From Exagen Inc.
Via GlobeNewswire
Earnings Scheduled For March 11, 2025
Via Benzinga
Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in Upcoming Investor Conferences
From Exagen Inc.
Via GlobeNewswire
Tuesday's session: top gainers and losers
Via Chartmill
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Reports Third Quarter 2024 Results
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
From Exagen Inc.
Via GlobeNewswire
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
From Exagen Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Exagen Inc. - Common Stock publicly traded?
Yes, Exagen Inc. - Common Stock is publicly traded.
What exchange does Exagen Inc. - Common Stock trade on?
Exagen Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exagen Inc. - Common Stock?
The ticker symbol for Exagen Inc. - Common Stock is XGN on the Nasdaq Stock Market
What is the current price of Exagen Inc. - Common Stock?
The current price of Exagen Inc. - Common Stock is 6.770
When was Exagen Inc. - Common Stock last traded?
The last trade of Exagen Inc. - Common Stock was at 06/25/25 04:00 PM ET
What is the market capitalization of Exagen Inc. - Common Stock?
The market capitalization of Exagen Inc. - Common Stock is 109.18M
How many shares of Exagen Inc. - Common Stock are outstanding?
Exagen Inc. - Common Stock has 109M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.